Skip to main content

Table 2 Qualitative interpretation of [18F]FES and [18F]FDG PET/CT

From: Comparison of diagnostic sensitivity of [18F]fluoroestradiol and [18F]fluorodeoxyglucose positron emission tomography/computed tomography for breast cancer recurrence in patients with a history of estrogen receptor-positive primary breast cancer

 

[18F]FES PET/CT

[18F]FDG PET/CT

Total

Positive

Equivocal

Negative

All recurrent breast cancer

Positive

25

5

2

32

Negative

11 (4*)

1

1

13

Total

36

6

3

45

ER-positive recurrent breast cancer

Positive

24

5

2

31

Negative

7

1

1

9

Total

31

6

3

40

  1. *Number of patients with ER-negative recurrent breast cancer